Stephen J. Tulipano
2021 - Stoke Therapeutics
In 2021, Stephen J. Tulipano earned a total compensation of $3.1M as Chief Financial Officer at Stoke Therapeutics.
Compensation breakdown
| Bonus | $8,320 |
|---|---|
| Non-Equity Incentive Plan | $183,040 |
| Option Awards | $2,484,499 |
| Salary | $416,000 |
| Other | $9,707 |
| Total | $3,101,566 |
Tulipano received $2.5M in option awards, accounting for 80% of the total pay in 2021.
Tulipano also received $8.3K in bonus, $183K in non-equity incentive plan, $416K in salary and $9.7K in other compensation.
Rankings
In 2021, Stephen J. Tulipano's compensation ranked 4,303rd out of 12,406 executives tracked by ExecPay. In other words, Tulipano earned more than 65.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,303 out of 12,406 | 65th |
Division Manufacturing | 1,775 out of 5,494 | 68th |
Major group Chemicals And Allied Products | 743 out of 2,369 | 69th |
Industry group Drugs | 663 out of 2,090 | 68th |
Industry Pharmaceutical Preparations | 470 out of 1,537 | 69th |
Source: SEC filing on April 27, 2023.
Tulipano's colleagues
We found two more compensation records of executives who worked with Stephen J. Tulipano at Stoke Therapeutics in 2021.